IQuity IsolateIBS-IBD

IQuity launched its IsolateIBS-IBD blood-based test for the identification of irritable bowel syndrom or inflammatory bowel disease. The Nashville, Tennessee-based company said the test can determine IBS and IBD earlier than is possible with other tests and has accuracy greater than 90 percent. It can determine whether a person's RNA profile indicates the presence of IBS or IBD, and within IBD it provides information to differentiate between Crohn's disease and ulcerative colitis.